Gaudium IVF reports Q2 FY27 results, appoints senior management, approves IPO fund variation
Gaudium IVF and Women Health · Healthcare Services
Key highlights
- Q2 FY27 standalone revenue ₹28.05 crore, profit after tax ₹8.20 crore; funds raised ₹90.00 crore via IPO
- Appointment of Dr. Ravish Manchanda as National Head – Operations Expansion & Strategy effective Nov 12, 2026
- Board approved variation in IPO object: substitution of 6 IVF centre locations and timeline revision to FY29, subject to shareholder approval via postal ballot
Original filing
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other financial results filings this fortnight
- Financial resultsTIPCO Engineering IndiaTipco Engineering India Ltd approves preferential allotment and reports H1 FY27 results
- Financial resultsAvalon TechnologiesAvalon Technologies Limited announces Q2 and H1 FY2027 unaudited financial results
- Financial resultsJindal Poly Investment & Finance CompanyJindal Poly Investment and Finance Company Ltd approves Q2 FY27 results and management changes
- Financial resultsSRIT IndiaSRIT India Limited announces unaudited Q2 and H1 FY2027 financial results and IPO completion
- Financial resultsRail Vikas NigamRail Vikas Nigam Limited approves Q2 FY2026 financials and corporate guarantee
- Financial resultsMcNally Bharat Engineering CompanyMcNally Bharat Engineering announces Q2 FY27 results and director appointment
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.